Regenerex Pharma (RGPX) Equity Average (2010 - 2025)
Regenerex Pharma (RGPX) reported Equity Average of -$4.6 million for Q3 2025, down 1.94% year-over-year from -$4.7 million in Q3 2024, and down 6.23% on a QoQ basis from -$4.4 million in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Equity Average data on file, last reported at -$4.6 million in Q3 2025.
- Quarterly Equity Average fell 1.94% year-over-year to -$4.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$4.6 million (down 1.94% YoY) and the FY2025 annual result came in at -$4.1 million, down 58.5% from the prior year.
- Equity Average eased to -$4.6 million in Q3 2025 per RGPX's latest filing, from -$4.4 million in the prior quarter.
- Across five years, Equity Average topped out at -$692786.0 in Q1 2021 and bottomed at -$4.9 million in Q4 2024.
- The 5-year median for Equity Average is -$1.1 million (2023), against an average of -$2.5 million.
- The widest annual swing landed in 2024, when Equity Average plunged 279.5%; it then retreated 1.94% in 2025.
- Tracing RGPX's Equity Average over 5 years: stood at -$919951.0 in 2021, then fell by 14.35% to -$1.1 million in 2022, then sank by 256.93% to -$3.8 million in 2023, then plunged by 30.65% to -$4.9 million in 2024, then grew by 5.75% to -$4.6 million in 2025.
- Per Business Quant, the three latest RGPX Equity Average figures stand at -$4.6 million (Q3 2025), -$4.4 million (Q2 2025), and -$4.6 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.62 Mn |
| Jun 30, 2025 | -4.35 Mn |
| Mar 31, 2025 | -4.60 Mn |
| Dec 31, 2024 | -4.91 Mn |
| Sep 30, 2024 | -4.54 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | -3.97 Mn |
| Dec 31, 2023 | -3.75 Mn |
| Sep 30, 2023 | -2.36 Mn |
| Jun 30, 2023 | -1.10 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -997,219.00 |
| Mar 31, 2022 | -961,392.50 |
| Dec 31, 2021 | -919,951.00 |
| Sep 30, 2021 | -885,856.00 |
| Jun 30, 2021 | -852,002.00 |
| Mar 21, 2021 | -692,786.00 |
| Dec 31, 2020 | -533,704.50 |
| Sep 30, 2020 | -503,977.00 |
| Jun 30, 2020 | -486,182.50 |
| Mar 31, 2020 | -461,126.00 |
| Dec 31, 2019 | -430,701.00 |
| Sep 30, 2019 | -411,189.00 |
| Jun 30, 2019 | -385,819.50 |
| Mar 31, 2019 | -361,459.00 |
| Dec 31, 2018 | -348,860.50 |
| Sep 30, 2018 | -342,083.50 |
| Jun 30, 2018 | -330,392.50 |
| Mar 31, 2018 | -319,231.00 |
| Dec 31, 2017 | -312,135.50 |
| Sep 30, 2017 | -302,851.50 |
| Jun 30, 2017 | -309,947.00 |
| Mar 31, 2017 | -507,292.50 |
| Nov 30, 2014 | -718,092.50 |
| Aug 31, 2014 | -718,092.50 |
| May 31, 2014 | -1.28 Mn |
| Feb 28, 2014 | -1.78 Mn |
| Nov 30, 2013 | -1.57 Mn |
| Aug 31, 2013 | -1.33 Mn |
| May 31, 2013 | -1.11 Mn |
| Feb 28, 2013 | -871,838.00 |
| Nov 30, 2012 | -517,356.50 |
| Aug 31, 2012 | -282,846.50 |
| May 31, 2012 | -279,057.00 |
| Feb 29, 2012 | -199,909.00 |
| Nov 30, 2011 | 108,368.00 |
| Aug 31, 2011 | 158,116.50 |
| Nov 30, 2010 | -18,330.00 |